Clinical trial of isophosphamide (NSC-109724)--results and side effects.

Clinical trial of isophosphamide (NSC-109724)--results and side effects. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Clinical trial of isophosphamide (NSC-109724)--results and side effects. Abstract Text:

D N Bremner,J S McCormick,J W Thomson,

Clinical trial of isophosphamide (NSC-109724)--results and side effects. Publishing Authors By Initials

DN Bremner,JS McCormick,JW Thomson,

For similar biological phenomena, cell phenomena, and immunity: biological phenomena: remission, spontaneous research abstracts see: biological phenomena, cell phenomena, and immunity: biological phenomena: remission, spontaneous research

PUBMED ID PMID:

MEDLINE DATE: 1974 Nov-Dec

Clinical trial of isophosphamide (NSC-109724)--results and side effects. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Cancer chemotherapy reports. Part 1

VOLUME: 58

Page Numbers: 889-93

Journal Abbreviation:

ISSN: 0069-0112

DAY: 20

MONTH: 02

YEAR: 2008

Clinical trial of isophosphamide (NSC-109724)--results and side effects. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 7607105

Clinical trial of isophosphamide (NSC-109724)--results and side effects. Keywords Mesh Terms:

KEYWORDS: Remission, Spontaneous

MESH TERMS: therapeutic use

Chemical & Substance for Abstract: Clinical trial of isophosphamide (NSC-109724)--results and side effects. Information

Substance Name: Cyclophosphamide

Registry Number: 50-18-0

Grant and Affiliation Information for Clinical trial of isophosphamide (NSC-109724)--results and side effects.

AFFILIATION:

Country: UNITED STATES

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Cancer Chemother Rep

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Clinical trial of isophosphamide NSC-109724--results and side effects Related Publications

• "Alternatively activated" dendritic cells preferentially secrete IL-10, expand Foxp3+CD4+ T cells, and induce long-term organ allograft survival in combination with CTLA4-Ig.
• African Americans at risk for increased iron stores or liver disease.
• An evaluation of the green chelant EDDS to enhance the stability of hydrogen peroxide in the presence of aquifer solids.
• An investigation of leakage tracts along stressed suture lines in phantom tissue.
• Bacterial chemoprophylaxis knowledge and practice among New Zealand dentists.
• Capsule endoscopy in the evaluation of gastrointestinal disease.
• Castleman's disease or angiofollicular hyperplasia as a solitary pulmonary nodule: case report.
• Cellular energy sensing and signaling by AMP-activated protein kinase.
• Diastereoselective Simmons-Smith cyclopropanations of allylic amines and carbamates.
• Dietary gangliosides enhance in vitro glucose uptake in weanling rats.
• Disagreement in spousal reports of current contraceptive use in sub-Saharan Africa.
• Discovery and SAR study of novel dihydroquinoline-containing glucocorticoid receptor agonists.
• Effects of waiting times and adjuvant chemotherapy in patients with glioblastoma multiforme.
• Evaluating beta-amino acids as enantioselective organocatalysts of the Hajos-Parrish-Eder-Sauer-Wiechert reaction.
• Frontiers of immunological tolerance.
• Growth factor-induced mobilization of dendritic cells in kidney and liver of rhesus macaques: implications for transplantation.
• Identification of dissociated non-steroidal glucocorticoid receptor agonists.
• Infusion of stably immature monocyte-derived dendritic cells plus CTLA4Ig modulates alloimmune reactivity in rhesus macaques.
• Intraparotid lymphadenitis caused by Haemophilus aphrophilus.
• Loss of intestinal fatty acid binding protein increases the susceptibility of male mice to high fat diet-induced fatty liver.
• Manipulation of dendritic cells as an approach to improved outcomes in transplantation.
• Plant diversity and ecosystem productivity: Theoretical considerations.
• Prognostic indices with brief and standard CBT for panic disorder: I. Predictors of outcome.
• Prognostic indices with brief and standard CBT for panic disorder: II. Moderators of outcome.
• PyPop update--a software pipeline for large-scale multilocus population genomics.
• Rapamycin-conditioned dendritic cells are poor stimulators of allogeneic CD4+ T cells, but enrich for antigen-specific Foxp3+ T regulatory cells and promote organ transplant tolerance.
• Selenium and iodine interactions with thyroid status.
• The FA4CT algorithm: a new model and tool for consumers to assess and filter health information on the Internet.
• The pharmacogenetics of methotrexate.
• Updated recommendations from the Canadian National Consensus Meeting on HER2/neu testing in breast cancer.